News tagged with national cancer institute
Long-term testicular cancer survivors at high risk for neurological side effects
Nov 25, 2009 |
not rated yet |
0
Long-term survivors of testicular cancer who were treated with cisplatin-based chemotherapy had more severe side effects, including neurological side effects and Raynaud-like phenomena, than men who were not treated with ...
Estrogen receptor-alpha, breast cancer patients and tamoxifen response
Nov 25, 2009 |
not rated yet |
0
Researchers have found evidence of a statistically significant survival benefit from adjuvant tamoxifen among patients whose estrogen receptor (ER)-positive tumors had high levels of phosphorylation of ER-alpha; at serine-118 ...
Drugs to treat anemia in cancer patients linked to thromboembolism
Nov 10, 2009 |
2.5 / 5 (2) |
1
Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., ...
Cancer patients and doctors report drug side effects differently
Nov 17, 2009 |
not rated yet |
0
In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue. At present, patient self-reporting, although important, ...
Bladder cancer risks increase over time for smokers
Nov 16, 2009 |
5 / 5 (1) |
1
Risk of bladder cancer for smokers has increased since the mid-1990s, with a risk progressively increasing to a level five times higher among current smokers in New Hampshire than that among nonsmokers in 2001-2004, according ...
Higher incidence of thyroid cancer in volcanic area of Sicily
Nov 05, 2009 |
not rated yet |
0
People living in volcanic areas may be at a higher risk for thyroid cancer, according to a new study published online November 5 in the Journal of the National Cancer Institute.
Antitumor activity of nutlin-3 in neuroblastoma with wild-type p53
Nov 10, 2009 |
not rated yet |
0
The small-molecule inhibitor nutlin-3 may be a viable treatment option for neuroblastoma patients with wild-type p53 activity, according to a new study published online November 10 in the Journal of the National Cancer In ...
Age-specific evaluation of HPV DNA testing vs. cytology screening
Nov 10, 2009 |
not rated yet |
0
Human papillomavirus (HPV) DNA testing with cytology triage is more sensitive than conventional cytology screening for detecting cervical lesions, according to a new study published online November 9 in the Journal of th ...
Detecting overall survival benefit derived from progression-free survival
Nov 10, 2009 |
not rated yet |
0
Overall survival (OS) may be a reasonable primary endpoint when the median survival postprogession (SSP) is less than 6 months, but it is too high a hurdle when SPP is longer than 12 months, according to a new study published ...
Link found between Trichomonas sexual infection and risk of aggressive prostate cancer
Sep 09, 2009 |
5 / 5 (2) |
0
A new study from Harvard School of Public Health (HSPH) and Brigham and Women's Hospital researchers has found a strong association between the common sexually transmitted infection, Trichomonas vaginalis, and risk of adv ...
Overdiagnosis since introduction of prostate cancer screening
Aug 31, 2009 |
not rated yet |
0
The introduction of prostate-antigen screening, or PSA, has resulted in over 1 million additional men over the last 23 years being diagnosed and treated for prostate cancer—most of whom were likely overdiagnosed, researchers ...
AIDS patients face higher risk of HPV-related cancers as immunosuppression grows
Jul 31, 2009 |
not rated yet |
0
Risk of human papillomavirus (HPV)-associated cancers is greater for people living with AIDS and increases with increasing immunosuppression, according to a new study published online July 31 in the Journal of the National Ca ...
Almost 30 percent of cancer studies report conflict of interest
May 11, 2009 |
3.7 / 5 (3) |
4
A new analysis finds that a considerable number of clinical cancer studies published in respected medical journals have financial connections to pharmaceutical companies. Published in the June 15, 2009 issue of CANCER, a peer ...
Study finds folic acid supplements linked to higher risk of prostate cancer
Mar 10, 2009 |
4.5 / 5 (2) |
0
A study led by researchers at the University of Southern California (USC) found that men who took a daily folic acid supplement of 1 mg daily had more than twice the risk of prostate cancer compared with men who took a placebo.
Teen smoking-cessation trial first to achieve significant quit rates
Oct 12, 2009 |
not rated yet |
0
For the first time, researchers at Fred Hutchinson Cancer Research Center have demonstrated that it is possible to successfully recruit and retain a large number of adolescent smokers from the general population into a smoking ...
